LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Swann, David (2013)
Languages: English
Types: Other
Subjects: R1, TS
Injections are one of the most common healthcare procedures performed in the world and the most deadly. Each year 16 billion injections are delivered using a pre-used syringe. This action kills 1.3 million patients and accounts for 26-million life years lost and 32% of all new Hepatitis B cases. To prevent such violations the auto-destruct syringe was introduced in 1986. This device has since become a prerequisite tool for immunization programmes (95%) but only used for 5% of all curative injections due to excessive cost. An inclusive two-year study has developed an effective innovation strategy to contribute to a reduction of curative syringe misuse by design. Precedent case studies, force-field analysis, and dialogues with global networks and specialists has captured the complexity of the challenge, sharpened the acuity of our strategic approach and identified a need for a frugal solution that offers unilateral benefits. The outcome of the research is a transformative label technology that synthesizes theories of risk perception, chromism and visual design. Primary beneficiaries include patients, families, healthcare providers, federal government and manufacturers in both industrialised markets and developing regions- as a package sterility monitor during the supply chain or as a visual label indicating prior use for syringes or any medical device. The significance of our research is recognized by Helene Moller, Head of UNICEF’s Health Techology Centre; Peter Evans, Former Head of WHO Procurement Worldwide; Stefan Gabriel 3M’s Vice President of New Ventures and Marc Koska OBE, Founder of the SafePoint Trust. A new global mandate is being prepared by the World Health Organisation in conjunction with SafePoint that seeks to homogenise the production, safety and quality of future WHO-certified AD syringes and injection devices for safety. This award-winning innovation is included as part of this initiative.
  • No references.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article